Bionovate Technologies (BIIO) 10-Q 15 May 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2019	May 14, 2019
Document And Entity Information
Entity Registrant Name	BIONOVATE TECHNOLOGIES CORP.
Entity Central Index Key	0001575420
Trading Symbol	biio
Document Period End Date	Mar. 31, 2019
Current Fiscal Year End Date	--06-30
Document Type	10-Q
Amendment Flag	false
Is Entity's Reporting Status Current?	Yes
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		15,579,749
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019
Entity Filer Category	Non-accelerated Filer

CONDENSED INTERIM BALANCE SHEET

CONDENSED INTERIM BALANCE SHEETS - USD ($)	Mar. 31, 2019	Jun. 30, 2018
Current Assets
Cash
Total Current Assets
TOTAL ASSETS
Current Liabilities
Accounts payable and accrued liabilities	93,004	40,506
Due to related parties	41,025	186,281
Convertible notes payable	166,573	82,895
Total Current Liabilities	300,602	309,682
TOTAL LIABILITIES	300,602	309,682
Stockholders' Deficit
Preferred stock: 90,000,000 authorized; $0.0001 par value - no shares issued and outstanding
Common stock: 100,000,000 authorized; $0.0001 par value 15,579,749 shares issued and outstanding	1,558	1,558
Additional paid in capital	2,225,311	2,056,059
Accumulated deficit	(2,527,471)	(2,367,299)
Total Deficit	(300,602)	(309,682)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

CONDENSED INTERIM BALANCE SHE_2

CONDENSED INTERIM BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2019	Jun. 30, 2018
Stockholders' Deficit
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares issued	15,579,749	15,579,749
Common stock, shares outstanding	15,579,749	15,579,749
Preferred stock, shares authorized	90,000,000	90,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

CONDENSED INTERIM STATEMENT OF

CONDENSED INTERIM STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Condensed Interim Statement Of Operations
Revenues
Operating Expenses
General and administration	875	1,361	5,805	71,540
Professional	4,517	9,211	33,025	16,000
Total operating expenses	5,392	10,572	38,830	87,540
Net loss from operations	(5,392)	(10,572)	(38,830)	(87,540)
Other income (expense)
Realized foreign currency gain (loss)	(136)	3,815	(168)	11,977
Interest expense	(19,806)	(3,497)	(121,174)	(13,641)
Loss on settlement of debt		(1,549,439)		(1,549,439)
Total other expense	(19,942)	(1,549,121)	(121,342)	(1,551,103)
Net loss before taxes	(25,334)	(1,559,693)	(160,172)	(1,638,643)
Net loss	(25,334)	(1,559,693)	(160,172)	(1,638,643)
Comprehensive income (loss)	(25,334)	(1,559,693)	(160,172)	(1,638,643)
Foreign currency adjustment				(14,013)
Comprehensive Loss	$ (25,334)	$ (1,559,693)	$ (160,172)	$ (1,652,656)
Basic and dilutive loss per share
Net loss	$ 0	$ (0.17)	$ (0.01)	$ (0.50)
Weighted average number of shares outstanding	15,579,749	9,348,576	15,579,749	3,271,757

STATEMENT OF STOCKHOLDERS_ EQUI

STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Total
Beginning Balance, Shares at Jun. 30, 2017	299,400
Beginning Balance, Amount at Jun. 30, 2017	$ 30	$ 383,372	$ 14,013	$ (626,563)	$ (229,148)
Foreign currency translation			(14,013)		(14,013)
Net loss				(33,780)	(33,780)
Ending Balance, Shares at Sep. 30, 2017	299,400
Ending Balance, Amount at Sep. 30, 2017	$ 30	383,372		(660,343)	(276,941)
Beginning Balance, Shares at Jun. 30, 2017	299,400
Beginning Balance, Amount at Jun. 30, 2017	$ 30	383,372	14,013	(626,563)	(229,148)
Net loss					(1,638,643)
Ending Balance, Shares at Mar. 31, 2018	15,579,400
Ending Balance, Amount at Mar. 31, 2018	$ 1,558	2,007,683		(2,265,206)	(255,965)
Beginning Balance, Shares at Sep. 30, 2017	299,400
Beginning Balance, Amount at Sep. 30, 2017	$ 30	383,372		(660,343)	(276,941)
Net loss				(45,170)	(45,170)
Ending Balance, Shares at Dec. 31, 2017	299,400
Ending Balance, Amount at Dec. 31, 2017	$ 30	383,372		(705,513)	(322,111)
Common stock issued for conversion of debt, Shares	2,280,000
Common stock issued for conversion of debt, Amount	$ 228	11,172			11,400
Common stock issued for settlement of debt, Shares	13,000,000
Common stock issued for settlement of debt, Amount	$ 1,300	1,613,139			1,614,439
Net loss				(1,559,693)	(1,559,693)
Ending Balance, Shares at Mar. 31, 2018	15,579,400
Ending Balance, Amount at Mar. 31, 2018	$ 1,558	2,007,683		(2,265,206)	(255,965)
Beginning Balance, Shares at Jun. 30, 2018	15,579,749
Beginning Balance, Amount at Jun. 30, 2018	$ 1,558	2,056,059		(2,367,299)	(309,682)
Debt forgiveness		85,523			85,523
Beneficial conversion feature		60,000			60,000
Net loss				(87,509)	(87,509)
Ending Balance, Shares at Sep. 30, 2018	15,579,749
Ending Balance, Amount at Sep. 30, 2018	$ 1,558	2,201,582		(2,454,808)	(251,668)
Beginning Balance, Shares at Jun. 30, 2018	15,579,749
Beginning Balance, Amount at Jun. 30, 2018	$ 1,558	2,056,059		(2,367,299)	(309,682)
Net loss					(160,172)
Ending Balance, Shares at Mar. 31, 2019	15,579,749
Ending Balance, Amount at Mar. 31, 2019	$ 1,558	2,225,311		(2,527,471)	(300,602)
Beginning Balance, Shares at Sep. 30, 2018	15,579,749
Beginning Balance, Amount at Sep. 30, 2018	$ 1,558	2,201,582		(2,454,808)	(251,668)
Beneficial conversion feature		17,302			17,302
Net loss				(47,329)	(47,329)
Ending Balance, Shares at Dec. 31, 2018	15,579,749
Ending Balance, Amount at Dec. 31, 2018	$ 1,558	2,218,884		(2,502,137)	(281,695)
Beneficial conversion feature		6,427			6,427
Net loss				(25,334)	(25,334)
Ending Balance, Shares at Mar. 31, 2019	15,579,749
Ending Balance, Amount at Mar. 31, 2019	$ 1,558	$ 2,225,311		$ (2,527,471)	$ (300,602)

CONDENSED INTERIM STATEMENT O_2

CONDENSED INTERIM STATEMENT OF CASH FLOWS (Unaudited( - USD ($)	9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (160,172)	$ (1,638,643)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Expenses paid by convertible notes	23,729
Loss on settlement of debt		1,549,439
Amortization of debt discount	83,729	2,746
Foreign currency adjustment	168	(11,979)
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	52,546	33,437
Accrued salary		65,000
Net cash provided by operating activities
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental cash flow information
Cash paid for interest
Cash paid for taxes
Non-cash transactions:
Beneficial conversion feature	83,729
Accounts payable paid by related party		26,801
Debt forgiveness	$ 85,523

NATURE AND CONTINUANCE OF OPERA

NATURE AND CONTINUANCE OF OPERATIONS	9 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
NOTE 1 - NATURE AND CONTINUANCE OF OPERATIONS	Bionovate Technologies Corp. (the “Company”, or the “Corporation”) was incorporated in the state of Nevada, United States on October 24, 2012 under the name MJP International Ltd. On December 1, 2017, the Company’s corporate name was changed to Bionovate Technologies Corp. The Corporation was formed and organized to capitalize on new opportunities found in the North American market for light-emitting diode (“LED”) lighting. With China as the manufacturing backbone of future LED products, the Corporation has set up an office in Guangzhou, China in search of high-quality products offered by reputable manufacturers to be introduced to Canada, the United States, and abroad. The Corporation has set out further details of the acquisition below as well as in Notes 3 and 4 to these consolidated financial statements. On February 5, 2016, Energy Alliance Labs Inc. (“Energy Alliance”), incorporated on February 5, 2016, entered into an agreement to acquire 80% of the issued and outstanding equity interests of Human Energy Alliance Laboratories Corp., an Idaho corporation (“HEAL”) from certain shareholders of HEAL for $80,000. The cash for the acquisition of shares was transferred to the shareholders on November 1, 2016 and that is when the acquisition closed. Subsequent to the transfer of cash, the previous shareholders of the Company owned 80% of the issued and outstanding shares of HEAL. On October 28, 2016, the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Liao Zu Guo, an individual residing in China, whereby the Company issued 80,000 shares of its common stock in exchange for 100% of the issued and outstanding equity interests of Energy Alliance. Subsequent to the execution of the Share Exchange Agreement, Liao Zu Gao became a member of the Board of Directors of the Company. On January 1, 2017, the Company entered into transfer agreement with Liao Zu Guo, whereby the Company transferred 100% of issued and outstanding equity interests of Energy Alliance for $20,000 for past services provided by Executive to the Company and agreed to assume the debt of Energy Alliance owed to the Liao Zu Guo in the aggregate amount of $28,239. On December 1, 2017, a majority of stockholders and the board of directors approved a reverse stock split of the issued and outstanding shares of common stock on a fifty (50) old for one (1) new basis. A Certificate of Amendment was filed with the Nevada Secretary of State on December 11, 2017 with an effective date of December 21, 2017. All share and per share information in these financial statements retroactively reflect this stock distribution. Our executive offices are located at 3006 E. Goldstone Drive, Suite 218, Meridian, ID 83642. Our telephone number is (208) 231 – 1606. Going Concern These condensed interim financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Corporation and its subsidiaries will be able to meet its obligations and continue its operations for the next fiscal year. Realizable values may be substantially different from carrying values as shown and these condensed interim financial statements, which do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Corporation be unable to continue as a going concern. At March 31, 2019, the Corporation had not yet achieved profitable operations and has an accumulated loss of $2,527,471 since inception. The Corporation expects to incur further losses, all of which casts substantial doubt about the Corporation’s ability to continue as a going concern. The Corporation’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management anticipates that additional funding will be in the form of equity financing from the sale of common stock. Management may also seek to obtain short-term loans from the directors of the Corporation. There are no current arrangements in place for equity funding or short-term loans.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
NOTE 2 -– BASIS OF PRESENTATION	The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Article 210 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the nine months ended March 31, 2019, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2018. For further information, refer to the financial statements and footnotes thereto included in the Corporation’s filed Form 10-K for the year ended June 30, 2018. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect application of policies and the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the year. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying unaudited condensed interim financial statements include the provision for unpaid loss and loss adjustment expenses which may result from product warranty provisions; valuation of deferred income taxes; valuation and impairment assessment of intangible assets; goodwill recoverability; and deferred acquisition costs.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Revenue Recognition Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: · identify the contract with a customer; · identify the performance obligations in the contract; · determine the transaction price; · allocate the transaction price to performance obligations in the contract; and · recognize revenue as the performance obligation is satisfied. We currently do not have operations, and its management seeks to acquire cash generating businesses. Fair Value of Financial Instrument The Corporation follows FASB ASC 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Corporation defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Corporation considers the principal or most advantageous market in which the Corporation would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Corporation applies FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Corporation has not elected the fair value option for any eligible financial instruments. Basic and Diluted Loss per Common Stock FASB ASC 260 requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per stock would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per common stock on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive.

CONVERTIBLE NOTE

CONVERTIBLE NOTE	9 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
NOTE 4 - CONVERTIBLE NOTE	Convertible notes payable at March 31, 2019 and June 30, 2018, consists of the following: March 31, June 30, 2019 2018 Dated November 1, 2016 $ 4,439 $ 4,439 Dated January 1, 2017 - 1 10,489 10,489 Dated January 1, 2017 - 2 6,200 6,200 Dated January 1, 2017 - 3 3,371 3,422 Dated June 30, 2017 9,969 9,969 Dated April 1, 2018 - 1 10,000 10,000 Dated April 1, 2018 - 2 10,000 10,000 Dated June 30, 2018 28,376 28,376 Dated July 5, 2018 - 1 30,000 - Dated July 5, 2018 - 2 15,000 - Dated July 5, 2018 - 3 15,000 - Dated December 31, 2018 17,302 - Dated March 31, 2019 6,427 Total convertible notes payable 166,573 82,895 Less: Unamortized debt discount - - Total convertible notes 166,573 82,895 Less: current portion of convertible notes 166,573 82,895 Long-term convertible notes $ - $ - For the nine months ended March 31, 2019 and 2018, the Company recognized interest expense of $37,445 and $10,895 and amortization of discount, included in interest expense, of $83,729 and $2,746, respectively. As of March 31, 2019, and June 30, 2018, the Company recorded accrued interest of $61,125 and $23,727, respectively Dated November 1, 2016 On November 1, 2016, the Company issued a convertible note with a conversion price of $0.005 to extinguish debt of $18,239. The convertible note is unsecured, bears interest at 4% per annum and due and payable on November 1, 2017. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $18,239. During the year ended June 30, 2018, the convertible note of $3,800 was converted into 760,000 shares of common stock. Dated January 1, 2017 - 1 On January 1, 2017, the Company issued a convertible note with a conversion price of $0.005 to extinguish amounts due to related parties of $10,000. The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $10,000. During the year ended June 30, 2018, the convertible note of $3,800 was converted into 760,000 shares of common stock. Dated January 1, 2017 - 2 On January 1, 2017, the Company issued a convertible note with a conversion price of $0.005 to extinguish amounts due to related parties of $14,289. The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $14,289. During the year ended June 30, 2018, the convertible note of $3,800 was converted into 760,000 shares of common stock. Dated January 1, 2017 - 3 On January 1, 2017, the Company issued a convertible note with a conversion price of $0.005 to extinguish amounts due to related parties of $3,352 (Canadian dollar (“CAD”) $4,500). The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $3,352 (CAD $4,500). The difference of amount was a result of change of exchange rate. Dated June 30, 2017 On June 30, 2017, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $9,969. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $9,969. Dated April 1, 2018 – 1 and 2 On April 1, 2018, the Company issued 2 convertible notes totaling of $20,000 with a conversion price of $0.01 to pay a purchase of a patent of $10,000. The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $20,000. Dated June 30, 2018 On June 30, 2018, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $28,376. The convertible note is unsecured, bears interest at 30% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $28,376. Dated July 5, 2018 – 1, 2 and 3 On June 30, 2018, the Company issued 3 convertible notes totaling of $60,000 with a conversion price of $0.01 to extinguish amounts due to related parties of $145,523. The convertible notes are unsecured, bears interest at 30% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $60,000. Dated December 31, 2018 On December 31, 2018, the Company issued a convertible note with a conversion price of $0.005 to pay operating expenses of $17,302. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $17,302. Dated March 31, 2019 On March 31, 2019, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $6,427. The convertible note is unsecured, bears interest at 20% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $6,427.

DUE TO RELATED PARTIES

DUE TO RELATED PARTIES	9 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
NOTE 5 - DUE TO RELATED PARTIES	As at March 31, 2019, the Company was obligated to shareholders for funds advanced to the Corporation for working capital. On July 5, 2018, the Company settled due to related parties of $145,523 (CAD 191,000) by issuing convertible notes of $60,000 to the third parties (Note 4). As a result, the Company recorded debt forgiveness of $85,523 as additional paid in capital. As of March 31, 2019, and June 30, 2018, due to related party was $41,025 and $186,281, respectively.

CAPITAL STOCK

CAPITAL STOCK	9 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
NOTE 6 -– CAPITAL STOCK	During the nine months ended March 31, 2019, there were no issuance of common stock. As at March 31, 2019 and June 30, 2018, 15,579,749 shares of common stock were issued and outstanding. As at March 31, 2019, there were no warrants or options outstanding.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
NOTE 7 -– SUBSEQUENT EVENTS	Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2019
Summary Of Significant Accounting Policies
Revenue Recognition	Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: · identify the contract with a customer; · identify the performance obligations in the contract; · determine the transaction price; · allocate the transaction price to performance obligations in the contract; and · recognize revenue as the performance obligation is satisfied. We currently do not have operations, and its management seeks to acquire cash generating businesses.
Fair Value of Financial Instrument	The Corporation follows FASB ASC 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Corporation defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Corporation considers the principal or most advantageous market in which the Corporation would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Corporation applies FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Corporation has not elected the fair value option for any eligible financial instruments.
Basic and Diluted Loss per Common Stock	FASB ASC 260 requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per stock would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per common stock on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive.

CONVERTIBLE NOTE (Tables)

CONVERTIBLE NOTE (Tables)	9 Months Ended
	Mar. 31, 2019
Convertible Note
Schedule of convertible note payable	March 31, June 30, 2019 2018 Dated November 1, 2016 $ 4,439 $ 4,439 Dated January 1, 2017 - 1 10,489 10,489 Dated January 1, 2017 - 2 6,200 6,200 Dated January 1, 2017 - 3 3,371 3,422 Dated June 30, 2017 9,969 9,969 Dated April 1, 2018 - 1 10,000 10,000 Dated April 1, 2018 - 2 10,000 10,000 Dated June 30, 2018 28,376 28,376 Dated July 5, 2018 - 1 30,000 - Dated July 5, 2018 - 2 15,000 - Dated July 5, 2018 - 3 15,000 - Dated December 31, 2018 17,302 - Dated March 31, 2019 6,427 Total convertible notes payable 166,573 82,895 Less: Unamortized debt discount - - Total convertible notes 166,573 82,895 Less: current portion of convertible notes 166,573 82,895 Long-term convertible notes $ - $ -

NATURE AND CONTINUANCE OF OPE_2

NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) - USD ($)	Feb. 05, 2016	Oct. 28, 2016	Mar. 31, 2019	Jun. 30, 2018
State of incorporation			Nevada
Date of incorporation			Oct. 24, 2012
Reverse stock split			Fifty (50) old for one (1) new basis
Accumulated deficit			$ (2,527,471)	$ (2,367,299)
January 1, 2017 [Member]
Assumption of due to related party			(28,239)
Consideration for past services provided by Executive to the company			$ 20,000
Human Energy Alliance Laboratories Corp [Member]
Issued and outstanding equity interests	80.00%
Liao Zu Guo [Member] | January 1, 2017 [Member] | MJP Holdings Ltd [Member]
Issued and outstanding equity interests			100.00%
Liao Zu Guo [Member] | Human Energy Alliance Laboratories Corp [Member]
Cash for acquisition of shares	$ 80,000
Share Exchange Agreement [Member] | Liao Zu Guo [Member]
Issued and outstanding equity interests		100.00%
Number of common shares in exchange for issued and outstanding equity interests		80,000

CONVERTIBLE NOTE (Details)

CONVERTIBLE NOTE (Details) - USD ($)	Mar. 31, 2019	Jun. 30, 2018
Total convertible notes payable	$ 166,573	$ 82,895
Less: Unamortized debt discount
Less: current portion of convertible notes	166,573	82,895
Long-term convertible notes
Convertible Notes Payable [Member] | November 1, 2016 [Member]
Total convertible notes payable	4,439	4,439
Convertible Notes Payable [Member] | January 1, 2017 - 1 [Member]
Total convertible notes payable	10,489	10,489
Convertible Notes Payable [Member] | January 1, 2017 - 2 [Member]
Total convertible notes payable	6,200	6,200
Convertible Notes Payable [Member] | January 1, 2017 - 3 [Member]
Total convertible notes payable	3,371	3,422
Convertible Notes Payable [Member] | June 30, 2017 [Member]
Total convertible notes payable	9,969	9,969
Convertible Notes Payable [Member] | April 1, 2018 - 1 [Member]
Total convertible notes payable	10,000	10,000
Convertible Notes Payable [Member] | April 1, 2018 - 2 [Member]
Total convertible notes payable	10,000	10,000
Convertible Notes Payable [Member] | June 30, 2018 [Member]
Total convertible notes payable	28,376	28,376
Convertible Notes Payable [Member] | July 5, 2018 - 1 [Member]
Total convertible notes payable	30,000
Convertible Notes Payable [Member] | July 5, 2018 - 2 [Member]
Total convertible notes payable	15,000
Convertible Notes Payable [Member] | July 5, 2018 - 3 [Member]
Total convertible notes payable	15,000
Convertible Notes Payable [Member] | December 31, 2018 [Member]
Total convertible notes payable	17,302
Convertible Notes Payable [Member] | Dated March 31, 2019 [Member]
Total convertible notes payable	$ 6,427

CONVERTIBLE NOTE (Details Narra

CONVERTIBLE NOTE (Details Narrative)	1 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2018USD ($)Integer$ / shares	Jun. 30, 2017USD ($)$ / shares	Mar. 31, 2019USD ($)Integer$ / shares	Mar. 31, 2018USD ($)	Jun. 30, 2018USD ($)$ / sharesshares
Amount due to relates parties	$ 186,281		$ 41,025		$ 186,281
Convertible note beneficial conversion feature			83,729
Amortization of debt discount			83,729	2,746
Interest expense			37,445	$ 10,895
Accrued interest	$ 23,727		$ 61,125		$ 23,727
Convertible Notes Payable [Member]
Convertible note conversion price | $ / shares	$ 0.01	$ 0.01			$ 0.01
Convertible note bearing interest	30.00%	35.00%
Convertible note beneficial conversion feature	$ 28,376	$ 9,969
Operating expenses	$ 28,376	$ 9,969
Convertible Notes Payable [Member] | Dated March 31, 2019 [Member]
Convertible note conversion price | $ / shares			$ 0.01
Convertible note bearing interest			20.00%
Operating expenses			$ 6,427
Convertible Notes Payable [Member] | December 31, 2018 [Member]
Convertible note conversion price | $ / shares			$ 0.005
Convertible note bearing interest			35.00%
Convertible note beneficial conversion feature			$ 17,302
Operating expenses			$ 17,302
Convertible Notes Payable [Member] | July 5, 2018 –1, 2 and 3 [Member]
Convertible note conversion price | $ / shares	$ 0.01				$ 0.01
Amount due to relates parties	$ 145,523				$ 145,523
Convertible note bearing interest	30.00%
Number of notes issued | Integer	3
Convertible note beneficial conversion feature	$ 60,000
Convertible note issued	$ 60,000				$ 60,000
Convertible Notes Payable [Member] | April 1, 2018 - 1 and 2 [Member]
Convertible note conversion price | $ / shares			$ 0.01
Patent of purchase			$ 10,000
Convertible note bearing interest			45.00%
Number of notes issued | Integer			2
Convertible note beneficial conversion feature			$ 20,000
Convertible note issued			$ 20,000
Convertible Notes Payable [Member] | January 1, 2017 [Member]
Convertible note conversion price | $ / shares			$ 0.005
Amount due to relates parties			$ 10,000
Convertible note bearing interest			45.00%
Convertible note beneficial conversion feature			$ 10,000
Common stock converted, shares | shares					760,000
Common stock converted, amount					$ 3,800
Convertible Notes Payable [Member] | January 1, 2017 - 2 [Member]
Convertible note conversion price | $ / shares			$ 0.005
Amount due to relates parties			$ 14,289
Convertible note bearing interest			45.00%
Convertible note beneficial conversion feature			$ 14,289
Common stock converted, shares | shares					760,000
Common stock converted, amount					$ 3,800
Convertible Notes Payable [Member] | January 1, 2017 - 3 [Member]
Convertible note conversion price | $ / shares			$ 0.005
Amount due to relates parties			$ 3,352
Convertible Notes Payable [Member] | November 1, 2016 [Member]
Convertible note conversion price | $ / shares			$ 0.005
Amount due to relates parties			$ 18,239
Convertible note bearing interest			4.00%
Maturity date			Nov. 1, 2017
Convertible note beneficial conversion feature			$ 18,239
Common stock converted, shares | shares					760,000
Common stock converted, amount					$ 3,800
Convertible Notes Two [Member] | January 1, 2017 - 3 [Member]
Convertible note bearing interest			45.00%
Convertible note beneficial conversion feature			$ 3,352

DUE TO RELATED PARTIES (Details

DUE TO RELATED PARTIES (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Jun. 30, 2018
Due to related parties	$ 41,025		$ 186,281
Debt forgiveness	85,523
On July 5, 2018 [Member]
Due to related parties	145,523
Convertible note issued	60,000
Debt forgiveness	$ 85,523

CAPITAL STOCK (Details Narrativ

CAPITAL STOCK (Details Narrative) - shares	Mar. 31, 2019	Jun. 30, 2018
Capital Stock
Common stock, shares issued	15,579,749	15,579,749
Common stock, shares outstanding	15,579,749	15,579,749
Warrants or options outstanding	0